Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-169,802
Closed -$389K 766
2022
Q3
$389K Buy
+169,802
New +$514K 0.01% 609
2021
Q4
Sell
-93,132
Closed -$1.17M 713
2021
Q3
$1.17M Buy
+93,132
New +$1.29M 0.02% 498

Other funds holding CLLS

Woodline Partners's CLLS Position: Q4 2022 in Review

Woodline Partners sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 169,802 shares — an estimated $389K sold.

Woodline Partners first reported a position in CLLS in Q3 2021 and held it in 2 quarters. The position peaked at $1.17M in Q3 2021. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

  • Woodline Partners reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
  • Woodline Partners sold 169,802 Cellectis shares in Q4 2022, an estimated $389K.
  • Woodline Partners first reported a position in Cellectis in Q3 2021 and held it in 2 quarters.
  • Woodline Partners's Cellectis position peaked at $1.17M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on Woodline Partners's 13F filing for Q4 2022, filed 14 Feb 2023.